Table 1.
Number | Model | Strategies for HIF Regulation | Involved HIF Isoforms | Is HIF Activated or Inhibited | Effects | Underlying Mechanisms | Reference |
---|---|---|---|---|---|---|---|
1 | Rats | cobalt | HIF-1 and HIF-2, | activated | attenuate AKI | apoptosis reduction via regulating mitochondrial pathways | [16] |
IRPTC, | HIF-1 | activated | improve IRPTC survival | ||||
2 | Rats; | Carbon monoxide preconditioning | HIF-1 | activated | attenuated AKI | apoptosis reduction | [17] |
HCK-8 cells | HIF-1 | activated | reduced apoptosis, increased proliferation | ||||
3 | Mice; | PHD inhibitor FG-4592 | HIF-1 | activated | attenuated AKI | apoptosis reduction, ameliorated inflammation | [18] |
HK-2 cells | HIF-1 | activated | reduced apoptosis | ||||
4 | Rats | deferiprone | HIF-1 | activated | attenuated AKI | reduce apoptosis with increased Mcl1 and survivin expression | [19] |
5 | Mice | EC-specific Phd2+/− mice |
HIF-1, HIF-2 | activated | attenuated AKI | induced antioxidative response | [149] |
6 | HK-2 cells | lentivirus-mediated HIF-1α-transfected hASCs | HIF-1 | activated | reduced apoptosis and improved cellular morphology | reduced apoptosis | [150] |
7 | Mice | lentivirus-mediated HIF-1α-transfected hASCs | HIF-1 | activated | attenuated AKI | reduced apoptosis, ameliorated inflammation | [151] |
IRPTC, immortalized rat proximal tubular cells; HCK-8, human renal proximal tubular cell line; HK-2, human proximal tubule epithelial cells; Mcl1, Myeloid cell leukemia-1; EC, endothelial cell; hASCs, Human adipose-derived stem cells.